Connect with us

Health

People With A.D.H.D. Are Likely to Die Significantly Earlier Than Their Peers, Study Finds

Published

on

People With A.D.H.D. Are Likely to Die Significantly Earlier Than Their Peers, Study Finds

A study of more than 30,000 British adults diagnosed with attention deficit hyperactivity disorder, or A.D.H.D., found that, on average, they were dying earlier than their counterparts in the general population — around seven years earlier for men, and around nine for women.

The study, which was published Thursday in The British Journal of Psychiatry, is believed to be the first to use all-cause mortality data to estimate life expectancy in people with A.D.H.D. Previous studies have pointed to an array of risks associated with the condition, among them poverty, mental health disorders, smoking and substance abuse.

The authors cautioned that A.D.H.D. is substantially underdiagnosed and that the people in their study — most of them diagnosed as young adults — might be among the more severely affected. Still, they described their findings as “extremely concerning,” highlighting unmet needs that “require urgent attention.”

“It’s a big number, and it is worrying,” said Joshua Stott, a professor of aging and clinical psychology at University College London and an author of the study. “I see it as likely to be more about health inequality than anything else. But it’s quite a big health inequality.”

The study did not identify causes of early death among people with A.D.H.D. but found that they were twice as likely as the general population to smoke or abuse alcohol and that they had far higher rates of autism, self-harming behaviors and personality disorders than the general population. In adulthood, Dr. Stott said, “they find it harder to manage impulses, and have more risky behaviors.”

Advertisement

He said health care systems might need to adjust in order to better serve people with A.D.H.D., who may have sensory sensitivity or difficulty managing time or communicating with clinicians during brief appointments. He said he hoped treatments for substance abuse or depression could be adapted for patients with A.D.H.D.

“If it’s about systems, it’s malleable,” he said. “This doesn’t have to be.”

Previous studies have pointed to an unusual number of early deaths for people with A.D.H.D. A 2022 meta-analysis in the journal JAMA Pediatrics found that deaths from unnatural causes, such as accidents or suicide, were 2.81 times higher among those diagnosed with A.D.H.D. than in the general population.

A 2019 study that used actuarial tables to predict life expectancy concluded that adults diagnosed with A.D.H.D. in childhood had an 8.4-year reduction in life expectancy compared with the general population, something the authors attributed to reduced education and income, higher rates of smoking and alcohol consumption and reduced sleep.

Russell Barkley, the lead author of that study, said the data made it clear that A.D.H.D. should not be seen as a childhood disorder, like bed-wetting, but as a lifelong problem.

Advertisement

“To me, the best analog is diabetes,” said Dr. Barkley, a retired professor of clinical psychology at Virginia Commonwealth University. “This is a disorder that you’ve got to manage, like high blood pressure, like cholesterol and diabetes. You’ve got to treat this for life.”

The new study examined 9,561,450 patients in Britain’s National Health Service primary care practices, among whom 30,039 had been diagnosed with A.D.H.D. Each person in the A.D.H.D. group was matched with 10 peers without the disorder for the purposes of comparison. Among those with A.D.H.D., 193 male patients and 148 female patients died during the follow-up period, which lasted from 2000 to 2019.

Stephen Hinshaw, a professor of psychology at the University of California, Berkeley, who studies A.D.H.D. but was not involved in the new British research, described the study as “a major finding,” the first analysis of deaths of subjects diagnosed with the disorder. He said it was unfortunate that the subjects’ causes of death were not included.

“There are risk factors to work on,” he said. “That is the key limitation of the study, because it would be really important to know, in terms of prevention, should we be focused on suicidality? Better diet and exercise? Depression?”

Diagnosis of A.D.H.D. has shifted in recent years, as clinicians concluded that many older people, especially women and people of color, had gone undiagnosed early in life and could benefit from treatment. As first-time diagnoses surged among older people, prevalence has remained consistent among children, at around 11 percent in the United States and 5 percent in Britain.

Advertisement

Dr. Stott said he hoped that, as these demographic changes took hold, health care systems would make more effort to identify the needs of neurodivergent patients. In past decades, he said, they may have been viewed dismissively by caregivers, as “the naughty kid at school.”

“If you’re constantly told, as a kid, sit down, stop being so naughty — if you talk to people with A.D.H.D., that is their experience — stop talking, go and sit outside,” he said. “It’s all of these things that wear down at your life chances, in many ways.”

Health

Video: Wii Bowling Takes Over Tulsa Retirement Homes

Published

on

Video: Wii Bowling Takes Over Tulsa Retirement Homes

new video loaded: Wii Bowling Takes Over Tulsa Retirement Homes

transcript

transcript

Wii Bowling Takes Over Tulsa Retirement Homes

Retirement communities in Tulsa, Okla., compete against one another in a Nintendo Wii Sports bowling league.

“That’s how you win.” “There you go, Ron.” “Way to go.”

Advertisement
Retirement communities in Tulsa, Okla., compete against one another in a Nintendo Wii Sports bowling league.

By Nick Oxford, Alisa Shodiyev Kaff and Alexandra E. Petri

June 19, 2026

Continue Reading

Health

Weight-loss drugs linked to ‘Ozempic ears’ and other cosmetic complaints, surgeons say

Published

on

Weight-loss drugs linked to ‘Ozempic ears’ and other cosmetic complaints, surgeons say

NEWYou can now listen to Fox News articles!

As the popularity of GLP-1 drugs continues to climb, significant weight loss associated with the medications has been linked to a growing list of cosmetic concerns.

Some surgeons report that more patients are seeking treatments for so-called “Ozempic earlobes,” which reportedly appear thinner, longer or more sagging after the loss of facial fat.

“The use of semaglutides causes you to lose fat across your body, including the small, fat pads of the earlobes,” facial plastic surgeon Sachin S. Parikh, MD, told NewBeauty.

OZEMPIC, OTHER SEMAGLUTIDES LINKED TO HAIR LOSS: HERE’S WHAT TO KNOW

Advertisement

“It’s important to note that semaglutides do not damage ear tissue or affect hearing in any way, so any intervention would be purely cosmetic,” added the California-based doctor.

Some of the potential treatments for “Ozempic earlobes” may include dermal filler, fat transfer, laser treatments or surgical earlobe reduction, according to the report.

As the popularity of GLP-1 drugs continues to climb, significant weight loss associated with the medications has been linked to a growing list of cosmetic concerns. (iStock)

Dr. Mohammed Asif from Duly Health and Care in Naperville, Illinois, said that while he hasn’t personally noticed an uptick in ear surgeries, he has seen a rise in other procedures due to GLP-1-triggered weight loss.

Some of those include panniculectomies (Ozempic skin removal surgery) and abdominoplasties (tummy tucks).

Advertisement

PLASTIC SURGERY TRENDS TAKE A SURPRISING TURN, AS DOCTORS SEE MORE PATIENTS ‘SIZING DOWN’

“There has been a significant increase in body contouring procedures among patients with GLP-1 weight loss,” Asif told Fox News Digital. 

“In my practice, I’ve seen a significant surge in breast lifts, panniculectomies (skin removal surgery), abdominoplasties (tummy tucks), brachioplasties (arm lifts) and thighplasties due to weight loss.”

TOP COSMETIC PROCEDURES REVEALED IN NEW REPORT: WHAT’S TRENDING AND WHY

Healing and recovery are “far greater and less complicated” than with bariatric surgery weight loss, Asif noted.

Advertisement

“This is due to the gradual weight loss achieved over time with GLP-1s.”

“Ozempic breast” is another common complaint, according to Dr. Michael Omidi, a double board-certified plastic surgeon practicing in Beverly Hills.

“There has been a significant increase in body contouring procedures among patients with GLP-1 weight loss,” a doctor told Fox News Digital. (iStock)

“Women in their 30s and 40s would not typically need a breast lift, but when you’re taking drugs like Ozempic or Wegovy that cause rapid weight loss, women can see gravity take its toll on their breasts,” he told Fox News Digital. 

“When women, especially younger ones, lose fat too fast, it causes the breasts, which are comprised of fat, glandular tissue and skin, to lose volume,” he went on. “The skin and supporting ligaments don’t always bouce back at the same rate as the weight loss, resulting in breasts that can appear saggy and deflated.”

Advertisement

NEW OBESITY TREATMENT MAY HELP PRESERVE MUSCLE DURING WEIGHT LOSS

Dr. Samuel Golpanian, a double board-certified plastic surgeon in Beverly Hills, said he has seen “dozens” of patients – men and women alike – seeking treatments for so-called “Ozempic butt” after significant weight loss.

“This is an unintended consequence of taking GLP-1s,” he told Fox News Digital.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Such dramatic weight loss in a short period of time causes the skin not to tighten quickly enough to keep up with the body’s changes. Our buttocks have a large amount of fat, so when that volume disappears quickly, you’ll develop a flatter, saggier behind.”

Advertisement

“Such dramatic weight loss in a short period of time causes the skin not to tighten quickly enough to keep up with the body’s changes,” a surgeon said. (iStock)

Kristy Hamilton, MD, a Houston-based surgeon who is a member of the American Society of Plastic Surgeons (ASPS), agreed that a growing number of patients are seeking skin-tightening procedures after losing large amounts of weight with GLP-1s.

“We’re absolutely seeing more of those patients, and I expect that trend to continue,” said Hamilton in an ASPS report.

CLICK HERE FOR MORE HEALTH STORIES

“People are losing as much as 100 pounds on this medication – and when you’re losing that amount, that’s significant. You’re certainly going to have excess skin afterward.”

Advertisement

The ASPS lists the following body-contouring procedures as the ones most frequently performed after substantial weight loss.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

  • Tummy tuck (abdominoplasty): Removes excess abdominal skin and fat
  • Lower body lift (belt lipectomy): Addresses the abdomen, buttocks, hips and thighs
  • Arm lift (brachioplasty): Removes hanging upper-arm skin
  • Thigh lift: Tightens excess skin of the inner thighs
  • Breast lift (mastopexy): Addresses sagging, deflated breasts after weight loss
  • Facelift/neck lift: Addresses facial volume loss and skin laxity after major weight loss

“People are losing as much as 100 pounds on this medication – and when you’re losing that amount, that’s significant. You’re certainly going to have excess skin afterward.” (iStock)

Experts say adequate protein intake and resistance training can help minimize the loss of lean muscle mass that often accompanies rapid weight loss, which could reduce some of the cosmetic concerns.

Golpanian also emphasized the importance of eating enough protein.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“It can be harder since your appetite is suppressed, but it’s so important to consume at least 110 grams of protein a day while taking a GLP-1 drug,” he advised. 

“Also, I say this to my patients all the time: You have to lift weights to keep your muscles from atrophying. Strength training can help build muscles and preserve your glutes.”

Advertisement
Continue Reading

Health

New At-Home DNA Test Reveals if GLP-1 Weight-Loss Drugs Will Work for You

Published

on

New At-Home DNA Test Reveals if GLP-1 Weight-Loss Drugs Will Work for You


Advertisement





GLP-1 Test Predicts If Weight Loss Drugs Will Work for You




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading
Advertisement

Trending